VIVEK SUBBIAH to MAP Kinase Signaling System
This is a "connection" page, showing publications VIVEK SUBBIAH has written about MAP Kinase Signaling System.
Connection Strength
0.313
-
Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies. JCO Precis Oncol. 2021; 5.
Score: 0.150
-
Clinical Development of BRAF plus MEK Inhibitor Combinations. Trends Cancer. 2020 09; 6(9):797-810.
Score: 0.138
-
Genomically Driven Tumors and Actionability across Histologies: BRAF-Mutant Cancers as a Paradigm. Mol Cancer Ther. 2016 04; 15(4):533-47.
Score: 0.026